Jazz Pharmaceuticals plc
JAZZ
$244.96
-$0.89-0.36%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.20B | 2.87B | 2.44B | 2.05B | 1.67B |
| Total Receivables | 880.90M | 836.30M | 830.75M | 764.36M | 714.00M |
| Inventory | 443.00M | 437.50M | 416.96M | 483.11M | 504.99M |
| Prepaid Expenses | 200.00M | 149.70M | 152.48M | 146.89M | 164.00M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 244.50M | 285.30M | 323.95M | 315.44M | 297.55M |
| Total Current Assets | 3.97B | 4.58B | 4.17B | 3.76B | 3.35B |
|
|
|||||
| Total Current Assets | 3.97B | 4.58B | 4.17B | 3.76B | 3.35B |
| Net Property, Plant & Equipment | 264.10M | 258.90M | 258.74M | 250.12M | 248.06M |
| Long-term Investments | 1.80B | 1.81B | 1.83B | 1.83B | 1.84B |
| Goodwill | 1.80B | 1.81B | 1.83B | 1.83B | 1.84B |
| Total Other Intangibles | 4.03B | 4.20B | 4.43B | 4.57B | 4.77B |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.02B | 1.00B | 971.41M | 952.97M | 728.39M |
| Total Assets | 11.08B | 11.86B | 11.66B | 11.36B | 10.94B |
|
|
|||||
| Total Accounts Payable | 128.50M | 100.00M | 122.06M | 152.23M | 89.37M |
| Total Accrued Expenses | 968.50M | 962.80M | 974.51M | 853.76M | 820.56M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.03B | 1.05B | 1.04B | 1.04B | 1.04B |
| Total Finance Division Other Current Liabilities | 103.10M | 138.40M | 101.33M | 224.56M | 118.92M |
| Total Other Current Liabilities | 103.10M | 138.40M | 101.33M | 224.56M | 118.92M |
| Total Current Liabilities | 2.23B | 2.25B | 2.24B | 2.27B | 2.07B |
|
|
|||||
| Total Current Liabilities | 2.23B | 2.25B | 2.24B | 2.27B | 2.07B |
| Long-Term Debt | 3.34B | 4.32B | 4.33B | 4.33B | 4.34B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 43.60M | 47.30M | 54.33M | 53.43M | 55.11M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 669.80M | 709.20M | 715.55M | 737.95M | 775.85M |
| Total Liabilities | 6.28B | 7.33B | 7.34B | 7.40B | 7.24B |
|
|
|||||
| Common Stock & APIC | 4.33B | 4.24B | 4.24B | 4.09B | 4.00B |
| Retained Earnings | 1.13B | 939.20M | 646.18M | 442.73M | 191.31M |
| Treasury Stock & Other | -661.90M | -650.40M | -568.07M | -569.37M | -485.24M |
| Total Common Equity | 4.80B | 4.53B | 4.32B | 3.96B | 3.71B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4.80B | 4.53B | 4.32B | 3.96B | 3.71B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 4.80B | 4.53B | 4.32B | 3.96B | 3.71B |
|
|
|||||